Compounds > n-methylaspartate
Page last updated: 2024-08-22

n-methylaspartate and Hearing Loss

n-methylaspartate has been researched along with Hearing Loss in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, HC; Chiu, CH; Huang, YS; Kang, HH; Li, IH; Liu, CT; Ma, KH; Shih, JH; Shiue, CY; Wang, CH1
Basile, AS; Berlin, C; Huang, JM; Skolnick, P; Webster, D; Xie, C1

Other Studies

2 other study(ies) available for n-methylaspartate and Hearing Loss

ArticleYear
Evaluation of brain SERT with 4-[
    Toxicology and applied pharmacology, 2019, 09-01, Volume: 378

    Topics: Animals; Benzylamines; Brain; Brain Stem; Dextromethorphan; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Hearing Loss; Male; N-Methylaspartate; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; RNA-Binding Proteins; Serotonergic Neurons; Serotonin Plasma Membrane Transport Proteins

2019
N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss.
    Nature medicine, 1996, Volume: 2, Issue:12

    Topics: Animals; Anti-Bacterial Agents; Cochlea; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Guinea Pigs; Hair Cells, Auditory; Hearing Loss; Hearing Tests; Kanamycin; Male; N-Methylaspartate; Neomycin; Piperidines; Prosencephalon; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate

1996